Donald E Mager

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Rheumatoid Arthritis

Multiple Myeloma

Inflammatory Response

Machine Learning

Top Venues

Journal of pharmacokinetics and pharmacodynamics

Clinical and translational science

Science translational medicine

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ezhilpavai Mohanan, Guofang Shen, Su-Ping Ren, Hsuan-Hao Fan, Kao Tang Ying Moua, Aleksandra Karolak, Russell C Rockne, Ryotaro Nakamura, David A Horne, Christopher G Kanakry, Donald E Mager, Jeannine S McCune
Challenges with sirolimus experimental data to inform QSP model of post-transplantation cyclophosphamide regimens. Clinical and translational science 17 (8) (2024)
Ezhilpavai Mohanan, Guofang Shen, Su-Ping Ren, Hsuan-Hao Fan, Kao Tang Ying Moua, Aleksandra Karolak, Russell C Rockne, Ryotaro Nakamura, David A Horne, Christopher G Kanakry, Donald E Mager, Jeannine S McCune
Challenges with sirolimus experimental data to inform QSP model of post-transplantation cyclophosphamide regimens. Clinical and translational science 17 (8) (2024)
Tomohisa Nakada, Donald E Mager
Systems model identifies baseline cytokine concentrations as potential predictors of rheumatoid arthritis inflammatory response to biologics. British journal of pharmacology 179 (16) (2022)
Kunle Odunsi, Feng Qian, Amit A Lugade, Han Yu, Melissa A Geller, Steven P Fling, Judith C Kaiser, Andreanne M Lacroix, Leonard D'Amico, Nirasha Ramchurren, Chihiro Morishima, Mary L Disis, Lucas Dennis, Patrick Danaher, Sarah Warren, Van Anh Nguyen, Sudharshan Ravi, Takemasa Tsuji, Spencer R Rosario, Wenjuan Zha, Alan Hutson, Song Liu, Shashikant Lele, Emese Zsiros, A J Robert McGray, Jessie Chiello, Richard Koya, Thinle Chodon, Carl D Morrison, Vasanta Putluri, Nagireddy Putluri, Donald E Mager, Rudiyanto Gunawan, Martin A Cheever, Sebastiano Battaglia, Junko Matsuzaki
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses. Science translational medicine 14 (636) (2022)
Li Zhang, Donald E Mager
Population-based meta-analysis of bortezomib exposure-response relationships in multiple myeloma patients. Journal of pharmacokinetics and pharmacodynamics 47 (1) (2020)
Peter Bloomingdale, Donald E Mager
Machine Learning Models for the Prediction of Chemotherapy-Induced Peripheral Neuropathy. Pharmaceutical research 36 (2) (2019)
Peter Bloomingdale, Van Anh Nguyen, Jin Niu, Donald E Mager
Boolean network modeling in systems pharmacology. Journal of pharmacokinetics and pharmacodynamics 45 (1) (2018)